undamentalytics Newsletter
Sign in

Envoy Medical, Inc. key statistics and ratios

In fiscal 2025, Envoy Medical, Inc. had an operating margin of -9240.7% and a current ratio of 0.54. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Operating margin<−999%<−999%<−999%<−999%<−999%
Net margin<−999%<−999%<−999%<−999%<−999%
Free-cash-flow margin<−999%<−999%<−999%<−999%<−999%
Return on assets−623.0%−552.7%−210.0%−236.4%−144.0%
Asset turnover0.090.060.020.020.01
Current ratio0.651.021.180.541.73
Debt to equity————0.0%
Interest cover (operating income ÷ interest)——n/mn/m—
Effective tax rate7.2%————
R&D as % of revenue>999%>999%>999%>999%>999%
SG&A as % of revenue>999%>999%———
Capital spending as % of revenue92.0%48.4%435.6%74.3%0.0%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 3 checks passed · June 30, 2026
What it owns · $24m
Short-term assets $22mLonger-term assets $2m
What it owes, and who funded it · $24m
Short-term liabilities $13mLonger-term liabilities $8mShareholders' equity $3m
  • Short-term assets cover short-term liabilities $22m of assets due within a year against $13m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $22m short-term assets against $8m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$24m against $2m of interest.

From Envoy Medical, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Low.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: COCH vs NXLCOCH vs QTEXCOCH vs PAVM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Envoy Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Envoy Medical, Inc.